Due for re-check: the scheduled review date of 2026-09-13 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0641-6083-25 · Promethazine Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc.
What is the package ndc for 0641-6083-25 · Promethazine Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc.?
For 0641-6083-25 · Promethazine Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc., package ndc is 0641-6083-25; generic name is Promethazine Hydrochloride Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01; source re-checked 2026-09-10.
"initial_posting_date": "11/21/2023", "package_ndc": "0641-6083-25", "generic_name": "Promethazine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "This presentation is temporarily on backorder. Expected in October 2026 timeframe"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0641-6083-25 verified
- Generic name
- Promethazine Hydrochloride Injection verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- This presentation is temporarily on backorder. Expected in October 2026 timeframe verified
- Initial posting date
- 11/21/2023 verified
- Last update date
- 08/13/2026 verified
- Days in shortage
- 1015 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Analgesia/Addiction verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/13/2026", "therapeutic_category": [ "Analgesia/Addiction", "Gastroenterology", "Pediatric", "Pulmonary/Allergy" ], "dosage_form": "Injection", "presentation": "Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000